<DOC>
	<DOCNO>NCT00682448</DOCNO>
	<brief_summary>We hypothesize metformin co-administered olanzapine well tolerate associate significantly less insulin resistance , weight gain dyslipidemia compare olanzapine plus placebo .</brief_summary>
	<brief_title>Metformin Prevention Metabolic Side-effects Zyprexa</brief_title>
	<detailed_description>Increased risk metabolic complication olanzapine therapy , relative antipsychotic , may lead clinician avoid use , despite evidence great efficacy . These problem may also pose therapeutic dilemma patient respond well olanzapine . Metabolic complication negatively impact morbidity mortality , impair quality life increase illness relapse secondary medication non-compliance . Thus far , pharmacologic agent co-administered olanzapine proven effective prevent untoward effect . The present study propose examine efficacy safety metformin attenuate metabolic side effect associate olanzapine .</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Diagnosis : Schizophrenia , Schizoaffective Disorder , Bipolar I II major depression psychotic feature start start take Olanzapine ( Zyprexa ) . Patients either history diabetes mellitus baseline FBG &gt; 126 two random blood sugar &gt; 200 OGTT glucose level &gt; 200 two hour glucose load 50 gram . ( All American Diabetes Association criterion diabetes mellitus ) . Baseline liver function test ( SGOT , SGPT , AP ) great 3X normal . Chronic alcoholism MDRD le 60 ml/1.73 m2 . Modification Diet Renal Disease ( MDRD ) Equation estimate glomerular filtration rate measure kidney function . This equation take account plasma creatinine , age , race gender , accurate estimation glomerular filtration rate serum creatinine alone . Patients unstable medical problem , include cardiovascular instability significant congestive heart failure ( determine study investigator ) . Prolonged QTc great 430 m baseline EKG . History lactic acidosis . History hypoglycemia . Current treatment metformin antidiabetic agent . Treatment antihyperlipidemic medication within 3 month randomization . Treatment olanzapine clozapine within 3 month randomization . Concurrent treatment ziprasidone , risperidone , quetiapine aripiprazole neuroleptic medication . Concurrent use OTC chromium , gymnema cimetidine prohibit . Patient may discontinue medication one day prior randomization . Current treatment corticosteroid .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Olanzapine</keyword>
	<keyword>Zyprexa</keyword>
	<keyword>Weight Gain</keyword>
	<keyword>Antipsychotics</keyword>
	<keyword>Metformin</keyword>
	<keyword>Glucophage</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Depression</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Side effect</keyword>
	<keyword>Metabolic complication</keyword>
	<keyword>Prevention</keyword>
	<keyword>Treatment</keyword>
	<keyword>Metabolic side effect olanzapine</keyword>
</DOC>